0001493152-24-028188.txt : 20240717
0001493152-24-028188.hdr.sgml : 20240717
20240717163012
ACCESSION NUMBER: 0001493152-24-028188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silberstein David S.
CENTRAL INDEX KEY: 0001812659
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39318
FILM NUMBER: 241122582
MAIL ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE, 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantern Pharma Inc.
CENTRAL INDEX KEY: 0001763950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 463973463
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: 972-277-1136
MAIL ADDRESS:
STREET 1: 1920 MCKINNEY AVENUE
STREET 2: 7TH FLOOR
CITY: DALLAS
STATE: TX
ZIP: 75201
FORMER COMPANY:
FORMER CONFORMED NAME: Lantern Pharma
DATE OF NAME CHANGE: 20190108
4
1
ownership.xml
X0508
4
2024-07-15
0
0001763950
Lantern Pharma Inc.
LTRN
0001812659
Silberstein David S.
1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS
TX
75201
1
0
0
0
0
Stock Option (Right to Buy)
4.35
2024-07-15
4
A
0
5000
0.00
A
2034-07-15
Common Stock
5000
5000
D
Stock Option (Right to Buy)
4.35
2024-07-15
4
A
0
5000
0.00
A
2034-07-15
Common Stock
5000
5000
D
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing August 15, 2024.
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing August 15, 2024.
/s/ David S. Silberstein
2024-07-17